Caleb Bell
Angel Investor @ Prime Movers Lab
San Francisco, United States
Caleb Bell is a Series A investor at Prime Movers Lab in San Francisco focused on Biopharma and Therapeutics. Caleb received a B.S. Degree in Biochemistry and Molecular Biology from Penn State University and a Ph.D. in Biophysical Chemistry from Stanford University. He completed the Stanford Graduate School of Business Ignite Program. Caleb's research interests include anaerobic microbiology, biological magnetic phenomena and various spectroscopicmethods for biochemical and biomedical research. He founded two companies prior to Bell Biosystems, Inc., and served as CEO of one for six years.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Caleb Bell invests in
Stages Caleb Bell invests in
Countries Caleb Bell invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biopharma 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Elevian’s founders discovered circulating blood factors that regulate aging, including GDF11, which broadly stimulate regeneration of brain, heart, pancreas, muscle, and other tissues. Elevian is developing therapeutics that stimulate regenerative capacity, to treat and prevent age-related disease. | $40M / Series A / Sep 16, 2021 |
Co-Investors
About Prime Movers Lab
Prime Movers Lab is a venture capital firm that seeks to invest in startups reinventing energy, transportation, infrastructure, manufacturing, human augmentation, and agriculture.
Prime Movers Lab Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anton Brevde
Chief of Staff
|
|||
Brad Pruente
Partner, Prime Movers Lab
|
|||
Amy Kruse
Partner & Principal Biologist
|
|||
Dakin Sloss
Founder & General Partner
|
|||
Gabrielle Sloss
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Caleb Bell invest in?
Caleb Bell invests primarily in Biopharma, Therapeutics and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Caleb Bell?
Public channels for Caleb Bell include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Caleb Bell last invest?
The most recent investment recorded for Caleb Bell closed in Sep 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
